{{Lowercase title}}
{{PBB|geneid=3757}}
'''hERG''' (the '''h'''uman '' '''E'''ther-à-go-go''-'''R'''elated '''G'''ene)，是指基因{{gene|KCNH2}}。该基因编码的蛋白质被称为 '''K<sub>v</sub>11.1'''，是[[钾离子通道|钾离子通道]]({{lang-en|[[w:en:potassium_channel|potassium ion channel]]}})的α亚基（{{lang-en|[[w:en:alpha_subunit|alpha subunit]]}}）。该基因编码的钾离子通道（有时简单地使用'hERG'表示）最为著名的是其对心脏的电位活性，可协调心跳（即，hERG通道介导在心脏动作电位中[[延迟整流钾电流|延迟整流钾电流]]--''I''<sub>Kr</sub>的复极化）。当这个通道介导电流通过细胞膜的能力受到抑制或妥协让步时，不论是由于药物的作用还是某些家族的基因突变引发，<ref name="Hedley">{{cite journal |author=Hedley PL|title=The genetic basis of long QT and short QT syndromes: a mutation update|journal=Human Mutation|volume=30 |issue=11 |pages=1486–511 |year=2009 |pmid=19862833 |doi=10.1002/humu.21106 |author2=Jorgensen P |author3=Schlamowitz S |display-authors=4 |last4=Wangari |first4=Romilda |last5=Moolman-Smook |first5=Johanna |last6=Brink |first6=Paul A. |last7=Kanters |first7=Jørgen K. |last8=Corfield |first8=Valerie A. |last9=Christiansen |first9=Michael}}</ref>，都会导致潜在的致命疾病——[[QT间期延长综合症|QT间期延长综合症]]。若干临床上成功的上市药物有抑制hERG的趋势，导致其在使用过程中也伴随着猝死的[[藥物不良反應|药物不良反应]]风险。因此，在药物研发过程中要尽量避免药物对[[抗靶标|抗靶标]]({{lang-en|[[w:en:antitarget|antitarget]]}})的hERG抑制。<ref name="Sanguinetti MC, Tristani-Firouzi M 2006 463–9">{{cite journal |author=Sanguinetti MC, Tristani-Firouzi M |title=hERG potassium channels and cardiac arrhythmia |journal=Nature |volume=440 |issue=7083 |pages=463–9 |date=March 2006 |pmid=16554806 |doi=10.1038/nature04710 |url=}}</ref> hERG还跟神经系统的某些细胞功能的调节<ref>{{cite journal |author=Chiesa N, Rosati B, Arcangeli A, Olivotto M, Wanke E |title=A novel role for HERG K+ channels: spike-frequency adaptation |journal=J. Physiol. (Lond.) |volume=501 ( Pt 2) |issue= 2|pages=313–8 |date=June 1997 |pmid=9192303 |pmc=1159479 |doi= 10.1111/j.1469-7793.1997.313bn.x|url=http://www.jphysiol.org/cgi/pmidlookup?view=long&pmid=9192303}}
{{cite journal |author=Overholt JL, Ficker E, Yang T, Shams H, Bright GR, Prabhakar NR |title=Chemosensing at the carotid body. Involvement of a HERG-like potassium current in glomus cells |journal=Adv. Exp. Med. Biol. |volume=475 |issue= |pages=241–8 |year=2000 |pmid=10849664 |doi= 10.1007/0-306-46825-5_22|url=}}</ref> 以及白血病细胞癌症特性的建立和维持<ref>{{cite journal |author=Arcangeli A |title=Expression and role of hERG channels in cancer cells |journal=Novartis Found. Symp. |volume=266 |issue= |pages=225–32; discussion 232–4 |year=2005 |pmid=16050271 |doi= 10.1002/047002142X.ch17|url=}}</ref>有关。

==命名==
1994年4月，威斯康星大学麦迪逊分校的杰夫（{{lang-en|Jeff Warmke}})和巴里（{{lang-en|Barry Ganetzky}}）在论文中首次命名和描述了hERG基因。<ref>{{cite journal |author=Warmke JW, Ganetzky B |title=A family of potassium channel genes related to eag in Drosophila and mammals |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=91 |issue=8 |pages=3438–42 |date=April 1994 |pmid=8159766 |pmc=43592 |doi=10.1073/pnas.91.8.3438 |url=http://www.pnas.org/cgi/pmidlookup?view=long&pmid=8159766 |access-date=2015-02-09 |archive-date=2019-10-17 |archive-url=https://web.archive.org/web/20191017044341/https://www.pnas.org/content/91/8/3438.long |dead-url=no }}</ref> 
hERG基因是首次发现于[[果蝇|果蝇]]的''Ether-à-go-go''基因的[[人类|人类]]同源类似物。 ''Ether-à-go-go''基因由现在任职于希望城国家医学中心（{{lang-en|City of Hope National Medical Center}}）的威廉·d·卡普兰在1960年代命名。当使用[[乙醚|乙醚]]麻醉拥有 ''Ether-à-go-go''基因突变的苍蝇时，它们的腿就开始颤抖，就像当时流行于加利福尼亚西好莱坞的威士忌摇摆舞（{{lang-en|Whisky A Go-Go}}）夜总会的舞蹈。


==Interactions==
HERG和 [[YWHAE|YWHAE]]之间存在相互作用。<ref name=pmid11953308>{{cite journal |last=Kagan |first=Anna |authorlink= |author2=Melman Yonathan F |author3=Krumerman Andrew |author4=McDonald Thomas V  |date=Apr 2002 |title=14-3-3 amplifies and prolongs adrenergic stimulation of HERG K+ channel activity |journal=EMBO J. |volume=21 |issue=8 |pages=1889–98 |publisher= |location = England| issn = 0261-4189| pmid = 11953308 |doi = 10.1093/emboj/21.8.1889 | bibcode = | oclc =| id = | url = | language = | format = | accessdate = | laysummary = | laysource = | laydate = | quote = |pmc=125975 }}</ref>
==生物功能==

<!--
 When this channel's ability to conduct electrical current across the cell membrane is inhibited or compromised, either by application of drugs or by rare mutations in some families,<ref name="Hedley">{{cite journal |author=Hedley PL|title=The genetic basis of long QT and short QT syndromes: a mutation update|journal=Human Mutation|volume=30 |issue=11 |pages=1486–511 |year=2009 |pmid=19862833 |doi=10.1002/humu.21106 |author2=Jorgensen P |author3=Schlamowitz S |display-authors=4 |last4=Wangari |first4=Romilda |last5=Moolman-Smook |first5=Johanna |last6=Brink |first6=Paul A. |last7=Kanters |first7=Jørgen K. |last8=Corfield |first8=Valerie A. |last9=Christiansen |first9=Michael}}</ref> it can result in a potentially fatal disorder called [[long_QT_syndrome|long QT syndrome]]; a number of clinically successful drugs in the market have had the tendency to inhibit hERG, and create a concomitant risk of sudden death, as a side-effect, which has made hERG inhibition an important [[antitarget|antitarget]] that must be avoided during drug development.<ref name="Sanguinetti MC, Tristani-Firouzi M 2006 463–9">{{cite journal |author=Sanguinetti MC, Tristani-Firouzi M |title=hERG potassium channels and cardiac arrhythmia |journal=Nature |volume=440 |issue=7083 |pages=463–9 |date=March 2006 |pmid=16554806 |doi=10.1038/nature04710 |url=}}</ref>  hERG has also been associated with modulating the functions of some cells of the nervous system<ref>{{cite journal |author=Chiesa N, Rosati B, Arcangeli A, Olivotto M, Wanke E |title=A novel role for HERG K+ channels: spike-frequency adaptation |journal=J. Physiol. (Lond.) |volume=501 ( Pt 2) |issue= 2|pages=313–8 |date=June 1997 |pmid=9192303 |pmc=1159479 |doi= 10.1111/j.1469-7793.1997.313bn.x|url=http://www.jphysiol.org/cgi/pmidlookup?view=long&pmid=9192303}}
{{cite journal |author=Overholt JL, Ficker E, Yang T, Shams H, Bright GR, Prabhakar NR |title=Chemosensing at the carotid body. Involvement of a HERG-like potassium current in glomus cells |journal=Adv. Exp. Med. Biol. |volume=475 |issue= |pages=241–8 |year=2000 |pmid=10849664 |doi= 10.1007/0-306-46825-5_22|url=}}</ref> and with establishing and maintaining cancer-like features in leukemic cells.<ref>{{cite journal |author=Arcangeli A |title=Expression and role of hERG channels in cancer cells |journal=Novartis Found. Symp. |volume=266 |issue= |pages=225–32; discussion 232–4 |year=2005 |pmid=16050271 |doi= 10.1002/047002142X.ch17|url=}}</ref>

==Biological function==
hERG forms the major portion of one of the ion channel proteins (the 'rapid' delayed rectifier current (''I''<sub>Kr</sub>)) that conducts potassium (K<sup>+</sup>) ions out of the muscle cells of the heart ([[Cardiac_muscle|cardiac myocytes]]), and this current is critical in correctly timing the return to the resting state ([[Cardiac_action_potential#Phase_3|repolarization]]) of the cell membrane during the cardiac action potential.<ref name="Sanguinetti MC, Tristani-Firouzi M 2006 463–9"/>  Sometimes, when referring to the pharmacological effects of drugs, the terms "hERG channels" and ''I''<sub>Kr</sub> are used interchangeably, but, in the technical sense, "hERG channels" can be made only by scientists in the laboratory; in formal terms, the naturally occurring channels in the body that include hERG are referred to by the name of the electrical current that has been measured in that cell type, so, for example, in the heart, the correct name is ''I''<sub>Kr</sub>.  This difference in nomenclature becomes clearer in the controversy as to whether the channels conducting ''I''<sub>Kr</sub> include other subunits (e.g., beta subunits<ref>{{cite journal |author=Weerapura M, Nattel S, Chartier D, Caballero R, Hébert TE |title=A comparison of currents carried by HERG, with and without coexpression of MiRP1, and the native rapid delayed rectifier current. Is MiRP1 the missing link? |journal=J. Physiol. (Lond.) |volume=540 |issue=Pt 1 |pages=15–27 |date=April 2002 |pmid=11927665 |pmc=2290231 |doi= 10.1113/jphysiol.2001.013296|url=http://www.ncbi.nlm.nih.gov/pubmed/11927665 |format= – <sup>[http://scholar.google.co.uk/scholar?hl=en&lr=&q=intitle%3AA+comparison+of+currents+carried+by+HERG%2C+with+and+without+coexpression+of+MiRP1%2C+and+the+native+rapid+delayed+rectifier+current.+Is+MiRP1+the+missing+link%3F&as_publication=J.+Physiol.+%28Lond.%29&as_ylo=2002&as_yhi=2002&btnG=Search Scholar search]</sup>}} {{dead link|date=April 2009}}{{cite journal |author=Abbott GW, Goldstein SA |title=Disease-associated mutations in KCNE potassium channel subunits (MiRPs) reveal promiscuous disruption of multiple currents and conservation of mechanism |journal=FASEB J. |volume=16 |issue=3 |pages=390–400 |date=March 2002 |pmid=11874988 |doi=10.1096/fj.01-0520hyp |url=}}{{cite journal |author=Abbott GW, Sesti F, Splawski I, et al. |title=MiRP1 forms IKr potassium channels with HERG and is associated with cardiac arrhythmia |journal=Cell |volume=97 |issue=2 |pages=175–87 |date=April 1999 |pmid=10219239 |doi= 10.1016/S0092-8674(00)80728-X|url=http://linkinghub.elsevier.com/retrieve/pii/S0092-8674(00)80728-X}}</ref>) or whether the channels include a mixture of different types ([[isoform|isoform]]s) of hERG,<ref>{{cite journal |author=Jones EM, Roti Roti EC, Wang J, Delfosse SA, Robertson GA |title=Cardiac ''I''<sub>Kr</sub> channels minimally comprise hERG 1a and 1b subunits |journal=J. Biol. Chem. |volume=279 |issue=43 |pages=44690–4 |date=October 2004 |pmid=15304481 |doi=10.1074/jbc.M408344200 |url=}}{{cite journal |author=Robertson GA, Jones EM, Wang J |title=Gating and assembly of heteromeric hERG1a/1b channels underlying ''I''<sub>Kr</sub> in the heart |journal=Novartis Found. Symp. |volume=266 |issue= |pages=4–15; discussion 15–8, 44–5 |year=2005 |pmid=16050259 |doi= 10.1002/047002142X.ch2|url=}}</ref> but, when the originally-discovered form of hERG<ref>{{cite journal |author=Warmke JW, Ganetzky B |title=A family of potassium channel genes related to eag in Drosophila and mammals |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=91 |issue=8 |pages=3438–42 |date=April 1994 |pmid=8159766 |pmc=43592 |doi= 10.1073/pnas.91.8.3438|url=http://www.pnas.org/cgi/pmidlookup?view=long&pmid=8159766}}{{cite journal |author=Trudeau MC, Warmke JW, Ganetzky B, Robertson GA |title=HERG, a human inward rectifier in the voltage-gated potassium channel family |journal=Science |volume=269 |issue=5220 |pages=92–5 |date=July 1995 |pmid=7604285 |doi= 10.1126/science.7604285|url=http://www.sciencemag.org/cgi/pmidlookup?view=long&pmid=7604285}}{{cite journal |author=Sanguinetti MC, Jiang C, Curran ME, Keating MT |title=A mechanistic link between an inherited and an acquired cardiac arrhythmia: HERG encodes the IKr potassium channel |journal=Cell |volume=81 |issue=2 |pages=299–307 |date=April 1995 |pmid=7736582 |doi= 10.1016/0092-8674(95)90340-2|url=http://linkinghub.elsevier.com/retrieve/pii/0092-8674(95)90340-2}}</ref> is experimentally transferred into cells that previously lacked hERG (i.e., [[heterologous|heterologous]] expression), a potassium ion channel is formed, and this channel has many signature features of the cardiac 'rapid' delayed rectifier current (''I''<sub>Kr</sub>),<ref name="Sanguinetti_ 1995">{{cite journal |author=Sanguinetti MC, Jiang C, Curran ME, Keating MT|title=A mechanistic link between an inherited and an acquired cardiac arrhythmia: HERG encodes the ''I''<sub>Kr</sub> potassium channel|journal= Cell |volume= 81 |issue= 2 |pages= 299–307 |year= 1995 |pmid= 7736582 | doi = 10.1016/0092-8674(95)90340-2}}</ref><ref>{{cite journal |author=Trudeau MC, Warmke JW, Ganetzky B, Robertson GA |title=HERG, a human inward rectifier in the voltage-gated potassium channel family |journal=Science |volume=269 |issue=5220 |pages=92–5 |date=July 1995 |pmid=7604285 |doi= 10.1126/science.7604285|url=http://www.sciencemag.org/cgi/pmidlookup?view=long&pmid=7604285}}</ref><ref>{{cite journal |author=Robertson GA, Jones EM, Wang J |title=Gating and assembly of heteromeric hERG1a/1b channels underlying I(Kr) in the heart |journal=Novartis Found. Symp. |volume=266 |issue= |pages=4–15; discussion 15–8, 44–5 |year=2005 |pmid=16050259 |doi= 10.1002/047002142X.ch2|url=}}</ref> including ''I''<sub>Kr</sub>'s inward rectification that results in the channel producing a 'paradoxical resurgent current' in response to repolarization of the membrane.<ref>{{cite journal |author=Robertson GA |title=LQT2 : amplitude reduction and loss of selectivity in the tail that wags the HERG channel |journal=Circ. Res. |volume=86 |issue=5 |pages=492–3 |date=March 2000 |pmid=10720408 |doi= 10.1161/01.res.86.5.492|url=http://circres.ahajournals.org/cgi/pmidlookup?view=long&pmid=10720408}}</ref>

==Structure==
A detailed atomic structure for hERG based on [[Crystallography|X-ray cystallography]] is not yet available, so structural details for hERG are based on analogy with other ion channels, computer models, pharmacology, and [[mutagenesis|mutagenesis]] studies.  In the laboratory the [[heterologous|heterologously expressed]] hERG potassium channel comprises 4 identical alpha subunits, which form the channel's pore through the [[cell_membrane|plasma membrane]].  Each hERG subunit consists of 6 transmembrane [[alpha_helix|alpha helices]], numbered S1-S6, a pore helix situated between S5 and S6, and cytoplasmically located [[N-terminus|N-]] and [[C-terminus|C-termini]]. The S4 helix contains a positively charged [[arginine|arginine]] or [[lysine|lysine]] amino acid residue at every 3rd position and is thought to act as a voltage-sensitive sensor, which allows the channel to respond to voltage changes by changing conformations between conducting and non-conducting states (called 'gating'). Between the S5 and S6 helices, there is an extracellular loop (known as 'the turret') and 'the pore loop', which begins and ends extracellularly but loops into the plasma membrane; the pore loop for each of the hERG subunits in one channel face into the ion-conducting pore and are adjacent to the corresponding loops of the 3 other subunits, and together they form the selectivity filter region of the channel pore.  The selectivity sequence, SVGFG, is very similar to that contained in bacterial [[KcsA_potassium_channel|KcsA channels]].<ref name="Sanguinetti MC, Tristani-Firouzi M 2006 463–9"/>  Although a full crystal structure for hERG is not yet available, a structure has been found for the cytoplasmic N-terminus, which was shown to contain a [[PAS_domain|PAS domain]] (aminoacid 26-135) that slows the rate of deactivation.<ref name="pmid9845367">{{cite journal | author = Morais Cabral JH, Lee A, Cohen SL, Chait BT, Li M, Mackinnon R | title = Crystal structure and functional analysis of the HERG potassium channel N terminus: a eukaryotic PAS domain | journal = Cell | volume = 95 | issue = 5 | pages = 649–55 |date=November 1998 | pmid = 9845367 | doi = 10.1016/S0092-8674(00)81635-9| url = http://linkinghub.elsevier.com/retrieve/pii/S0092-8674(00)81635-9 }}</ref>

==Genetics==
Loss of function mutations in this channel may lead to [[long_QT_syndrome|long QT syndrome]] (LQT2), while gain of function mutations may lead to [[short_QT_syndrome|short QT syndrome]]. Both clinical disorders stem from ion channel dysfunction (so-called [[Channelopathy|channelopathies]]) that can lead to the risk of potentially fatal cardiac [[arrhythmia|arrhythmia]]s (e.g., ''[[torsades_de_pointes|torsades de pointes]]''), due to repolarization disturbances of the cardiac action potential.<ref name="Sanguinetti_ 1995"/><ref name="Moss">{{cite journal |author=Moss AJ, Zareba W, Kaufman ES, Gartman E, Peterson DR, Benhorin J, Towbin JA, Keating MT, Priori SG, Schwartz PJ, Vincent GM, Robinson JL, Andrews ML, Feng C, Hall WJ, Medina A, Zhang L, Wang Z|title=Increased risk of arrhythmic events in long-QT syndrome with mutations in the pore region of the human ether-a-go-go-related gene potassium channel|journal= Circulation |volume= 105 |issue= 7 |pages= 794–9 |year= 2002 |pmid= 11854117 | doi = 10.1161/hc0702.105124}}</ref>  There are far more hERG mutations described for long QT syndrome than for short QT syndrome.<ref name="Hedley" />

==Drug interactions==
This channel is also sensitive to drug binding, as well as decreased extracellular potassium levels, both of which can result in decreased channel function and drug-induced [[Long_QT_syndrome#Acquired_Long_QT_Syndrome|(acquired) long QT syndrome]]. Among the drugs that can cause QT prolongation, the more common ones include antiarrhythmics (especially Class 1A and Class III), anti-psychotic agents, and certain antibiotics (including quinolones and macrolides).<ref name="Sanguinetti">{{cite journal |author=Sanguinetti MC, Tristani-Firouzi M|title=hERG potassium channels and cardiac arrhythmia|journal= Nature |volume= 440 |issue= 7083 |pages= 463–9 |year= 2006 |pmid= 16554806 | doi = 10.1038/nature04710}}</ref>

Although there exist other potential targets for cardiac adverse effects, the vast majority of drugs associated with acquired QT prolongation are known to interact with the hERG potassium channel. One of the main reasons for this phenomenon is the larger inner vestibule of the hERG channel, thus providing more space for many different drug classes to bind and block this potassium channel.<ref name="Milnes">{{cite journal |author=Milnes JT, Crociani O, Arcangeli A, Hancox JC, Witchel HJ|title= Blockade of HERG potassium currents by fluvoxamine: incomplete attenuation by S6 mutations at F656 or Y652|url=https://archive.org/details/sim_british-journal-of-pharmacology_2003-07_139_5/page/887|journal= Br J Pharmacol |volume= 139 |issue= 5 |pages= 887–98 |year= 2003 |pmid= 12839862 | doi = 10.1038/sj.bjp.0705335 |pmc=1573929}}</ref>

Due to the awareness of the potential danger of such QT drugs the regulatory authorities issued recommendations for the establishment of cardiac safety during preclinical drug development: ICH S7B, The nonclinical evaluation of the potential for delayed ventricular repolarization (QT interval prolongation) by human pharmaceuticals, issued as CHMP/ICH/423/02, adopted by CHMP in May 2005. Preclinical hERG studies should be accomplished in [[Good_Laboratory_Practice|GLP]] environment.

==Naming==
The hERG gene was first named and described in a paper by Jeff Warmke and Barry Ganetzky, then both at the [[University_of_Wisconsin–Madison|University of Wisconsin–Madison]].<ref>{{cite journal |author=Warmke JW, Ganetzky B |title=A family of potassium channel genes related to eag in Drosophila and mammals |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=91 |issue=8 |pages=3438–42 |date=April 1994 |pmid=8159766 |pmc=43592 |doi= 10.1073/pnas.91.8.3438|url=http://www.pnas.org/cgi/pmidlookup?view=long&pmid=8159766}}</ref>  The hERG gene is the human homolog of the ''Ether-à-go-go'' gene found in the [[Drosophila|Drosophila]] fly;  ''Ether-à-go-go'' was named in the 1960s by William D. Kaplan, now at the [[City_of_Hope_National_Medical_Center|City of Hope]] Hospital in [[Duarte,_California|Duarte, California]]. When flies with mutations in the ''Ether-à-go-go'' gene are anaesthetised with [[diethyl_ether|ether]], their legs start to shake, like the dancing then popular at the [[Whisky_A_Go-Go|Whisky A Go-Go]] nightclub in [[West_Hollywood,_California|West Hollywood, California]].

==Interactions==
HERG has been shown to [[Protein-protein_interaction|interact]] with [[YWHAE|YWHAE]].<ref name=pmid11953308>{{cite journal |last=Kagan |first=Anna |authorlink= |author2=Melman Yonathan F |author3=Krumerman Andrew |author4=McDonald Thomas V  |date=Apr 2002 |title=14-3-3 amplifies and prolongs adrenergic stimulation of HERG K+ channel activity |journal=EMBO J. |volume=21 |issue=8 |pages=1889–98 |publisher= |location = England| issn = 0261-4189| pmid = 11953308 |doi = 10.1093/emboj/21.8.1889 | bibcode = | oclc =| id = | url = | language = | format = | accessdate = | laysummary = | laysource = | laydate = | quote = |pmc=125975 }}</ref>

==See also==
* [[Voltage-gated_potassium_channel|Voltage-gated potassium channel]]

==References==
{{Reflist|2}}

==Further reading==
{{refbegin | 2}}
{{PBB_Further_reading
| citations =
*{{cite journal  | author=Vincent GM |title=The molecular genetics of the long QT syndrome: genes causing fainting and sudden death |journal=Annu. Rev. Med. |volume=49 |issue=  |pages= 263–74 |year= 1998 |pmid= 9509262 |doi= 10.1146/annurev.med.49.1.263 }}
*{{cite journal  | author=Ackerman MJ |title=The long QT syndrome: ion channel diseases of the heart | url=https://archive.org/details/sim_mayo-clinic-proceedings_1998-03_73_3/page/250 |journal=Mayo Clin. Proc. |volume=73 |issue= 3 |pages= 250–69 |year= 1998 |pmid= 9511785 |doi=10.4065/73.3.250  }}
*{{cite journal  | author=Taglialatela M, Castaldo P, Pannaccione A, et al. |title=Human ether-a-gogo related gene (HERG) K+ channels as pharmacological targets: present and future implications |journal=Biochem. Pharmacol. |volume=55 |issue= 11 |pages= 1741–6 |year= 1998 |pmid= 9714291 |doi=10.1016/S0006-2952(98)00002-1  }}
*{{cite journal  | author=Bjerregaard P, Gussak I |title=Short QT syndrome: mechanisms, diagnosis and treatment |journal=Nature Clinical Practice Cardiovascular Medicine |volume=2 |issue= 2 |pages= 84–7 |year= 2005 |pmid= 16265378 |doi= 10.1038/ncpcardio0097 }}
*{{cite journal  | author=Gutman GA, Chandy KG, Grissmer S, et al. |title=International Union of Pharmacology. LIII. Nomenclature and molecular relationships of voltage-gated potassium channels |journal=Pharmacol. Rev. |volume=57 |issue= 4 |pages= 473–508 |year= 2006 |pmid= 16382104 |doi= 10.1124/pr.57.4.10 }}
}}
{{refend}}

==External links==
* [http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=gene&part=rws  GeneReviews/NIH/NCBI/UW entry on Romano-Ward Syndrome]
* [http://www.herg.ch The HERG Association]
* [http://www.ich.org International Conference on Harmoniozation]
* [http://flybase.bio.indiana.edu/.bin/fbidq.html?FBgn0000535&resultlist=fbgn26618.data Drosphila flybase entry for ''erg'']
* [http://www.schizophreniaforum.org/new/detail.asp?id=1521 Special K: Primate-specific Potassium Channel Variant Implicated in Schizophrenia] - [[Schizophrenia_Research_Forum|Schizophrenia Research Forum]].

{{PDB Gallery|geneid=3757}}
{{Ion channels|g3}}
-->
<!-- The PBB_Controls template provides controls for Protein Box Bot, please see Template:PBB_Controls for details. -->
==参考文献==
{{Reflist|2}}

{{PBB_Controls
| update_page = yes
| require_manual_inspection = no
| update_protein_box = yes
| update_summary = no
| update_citations = yes
}}
{{离子通道}}
{{DEFAULTSORT:Herg}}
[[Category:离子通道|Category:离子通道]]
[[Category:药物化学|Category:药物化学]]
[[Category:藥理學|Category:藥理學]]